Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
2 studies found for:    AZD2820

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Terminated To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses
Condition: Obesity
Interventions: Drug: AZD2820;   Drug: Placebo
2 Completed To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending Doses
Condition: Healthy
Interventions: Drug: AZD2820;   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years